Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px
Financing › Details

Pontifax–SEVERAL: investment, 201710–201801 closing $240m of new fifth fund

 

Period Period 2018-01-01
Organisations Money taker Pontifax (Fund V)
  Group Pontifax (Group)
  Money source SEVERAL
Products Product Pontifax (Fund V)
  Product 2 LIFE SCIENCES
Person Person Nussbaum, Ran (Pontifax 200712 Managing Partner also CEO of Biomedix Incubator)
Document Source Orbach, Meir [CalcalisTech]. (1/1/18). "News: Pontifax Raises a $240 Million Fifth Fund. Life Sciences-focused Venture Capital Firm Pontifax Is Expected to Invest Most of the New Fund in the Pharmaceutical Industry".
     

   
Record changed: 2018-01-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Pontifax (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News How Covid Effects the Brain 650x300px




» top